KQ · Healthcare

ST Pharm Co.Ltd (237690)

Pharmaceuticals

ST Pharm Co.Ltd (237690) is listed on KQ in the Healthcare sector. Industry: Pharmaceuticals. As of 2026-05-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 237690

P/E ratio

18.00

ST Pharm Co.Ltd (237690) — FAQ

What is 237690's P/E ratio?

The price-to-earnings (P/E) ratio for ST Pharm Co.Ltd (237690) is 18.00 (data as of 2026-05-24).

Does ST Pharm Co.Ltd pay a dividend?

Dividend yield is not available in the current snapshot for ST Pharm Co.Ltd (237690). Check the MyAverix Finance app for the latest dividend data.

What sector is ST Pharm Co.Ltd in?

ST Pharm Co.Ltd (237690) is classified in the Healthcare sector (Pharmaceuticals industry).

What exchange is 237690 listed on?

237690 is listed on KQ.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)